HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Ganley Puts Rx Switch Studies In “Real World” Context

This article was originally published in The Tan Sheet

Executive Summary

Accurate extrapolation of actual-use data into broader consumer settings will be a defining measure of success for switching chronic disease drugs in the future, according to FDA Office of Nonprescription Products Director Charles Ganley, MD

You may also be interested in...

FDA Sets Outcomes Benchmarks For Actual Use Trials

FDA is providing OTC switch application sponsors with pre-defined benchmarks for actual use trials, Center for Drug Evaluation and Research executive Andrea Leonard-Segal says

NDAC Approach To OTC Switches Highlighted At Corticosteroid Meeting

A joint FDA advisory committee meeting evaluating the Rx-to-OTC switch prospects of topical corticosteroids underscored the different approaches to switches taken by OTC drug advisors and more cautious prescribers with category-specific expertise

Mevacor Daily Regimen Compliance Questioned By FDA Committees

A joint FDA advisory committee review of J&J/Merck's nonprescription Mevacor Daily centered in part on long-term consumer compliance with the indicated cholesterol-lowering regimen

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts